JP2025504382A5 - - Google Patents
Info
- Publication number
- JP2025504382A5 JP2025504382A5 JP2024540933A JP2024540933A JP2025504382A5 JP 2025504382 A5 JP2025504382 A5 JP 2025504382A5 JP 2024540933 A JP2024540933 A JP 2024540933A JP 2024540933 A JP2024540933 A JP 2024540933A JP 2025504382 A5 JP2025504382 A5 JP 2025504382A5
- Authority
- JP
- Japan
- Prior art keywords
- azacycloundecine
- methoxytetrahydro
- oxazepine
- pyrazino
- decahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025118767A JP2025160251A (ja) | 2022-01-21 | 2025-07-15 | １，３，４，７－テトラヒドロ－２Ｈ－ピロロ［３’，２’：５，６］ピリド［２，３－Ｂ］［１，４］オキサアゼピンＢｃｌ－２阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267018P | 2022-01-21 | 2022-01-21 | |
| US63/267,018 | 2022-01-21 | ||
| PCT/US2023/060944 WO2023141536A1 (en) | 2022-01-21 | 2023-01-20 | 1,3,4,7-tetrahydro-2h-pyrrolo [3',2':5,6] pyrido[2,3-b] [1,4] oxazepine bc1-2 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118767A Division JP2025160251A (ja) | 2022-01-21 | 2025-07-15 | １，３，４，７－テトラヒドロ－２Ｈ－ピロロ［３’，２’：５，６］ピリド［２，３－Ｂ］［１，４］オキサアゼピンＢｃｌ－２阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025504382A JP2025504382A (ja) | 2025-02-12 |
| JP2025504382A5 true JP2025504382A5 (https=) | 2025-06-09 |
| JP7714811B2 JP7714811B2 (ja) | 2025-07-29 |
Family
ID=85382827
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540933A Active JP7714811B2 (ja) | 2022-01-21 | 2023-01-20 | １，３，４，７－テトラヒドロ－２Ｈ－ピロロ［３’，２’：５，６］ピリド［２，３－Ｂ］［１，４］オキサアゼピンＢｃｌ－２阻害剤 |
| JP2025118767A Pending JP2025160251A (ja) | 2022-01-21 | 2025-07-15 | １，３，４，７－テトラヒドロ－２Ｈ－ピロロ［３’，２’：５，６］ピリド［２，３－Ｂ］［１，４］オキサアゼピンＢｃｌ－２阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025118767A Pending JP2025160251A (ja) | 2022-01-21 | 2025-07-15 | １，３，４，７－テトラヒドロ－２Ｈ－ピロロ［３’，２’：５，６］ピリド［２，３－Ｂ］［１，４］オキサアゼピンＢｃｌ－２阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11964990B2 (https=) |
| EP (1) | EP4466273A1 (https=) |
| JP (2) | JP7714811B2 (https=) |
| KR (1) | KR20240136972A (https=) |
| CN (1) | CN119053610A (https=) |
| AR (1) | AR128310A1 (https=) |
| AU (1) | AU2023210279A1 (https=) |
| CA (1) | CA3242074A1 (https=) |
| CO (1) | CO2024009334A2 (https=) |
| IL (1) | IL312709A (https=) |
| MX (1) | MX2024008840A (https=) |
| TW (1) | TW202340210A (https=) |
| WO (1) | WO2023141536A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202340210A (zh) * | 2022-01-21 | 2023-10-16 | 美商艾伯維有限公司 | １，３，４，７－四氫－２Ｈ－吡咯并［３＇，２＇：５，６］吡啶并［２，３－ｂ］［１，４］氮呯Ｂｃｌ－２抑制劑 |
| CN117820134A (zh) * | 2024-01-10 | 2024-04-05 | 山东盛安贝新材料有限公司南京分公司 | 一种顺式-3-甲氧基环丁胺盐酸盐的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111511748B (zh) | 2017-08-23 | 2023-05-02 | 广州麓鹏制药有限公司 | Bcl-2抑制剂 |
| US11903950B2 (en) | 2018-08-22 | 2024-02-20 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
| WO2020140005A2 (en) | 2018-12-29 | 2020-07-02 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| US20220372042A1 (en) | 2019-10-03 | 2022-11-24 | Newave Pharmaceutical Inc. | Condensed heterocycles as bcl-2 inhibitors |
| WO2021083135A1 (en) | 2019-10-28 | 2021-05-06 | Beigene, Ltd. | Bcl-2 INHIBITORS |
| WO2021133817A1 (en) | 2019-12-27 | 2021-07-01 | Guangzhou Lupeng Pharmaceutical Company Ltd. | 1h-pyrrolo[2,3-b]pyridine derivatives as bcl-2 inhibitors for the treatment of neoplastic and autoimmune diseases |
| JP7849296B2 (ja) | 2020-02-24 | 2026-04-21 | グアンジョウ・ルペン・ファーマシューティカル・カンパニー・リミテッド | Ｂｃｌ２阻害剤を含むホットメルト押出し固体分散体 |
| TW202340210A (zh) * | 2022-01-21 | 2023-10-16 | 美商艾伯維有限公司 | １，３，４，７－四氫－２Ｈ－吡咯并［３＇，２＇：５，６］吡啶并［２，３－ｂ］［１，４］氮呯Ｂｃｌ－２抑制劑 |
-
2023
- 2023-01-19 TW TW112102814A patent/TW202340210A/zh unknown
- 2023-01-19 US US18/156,987 patent/US11964990B2/en active Active
- 2023-01-20 IL IL312709A patent/IL312709A/en unknown
- 2023-01-20 KR KR1020247023725A patent/KR20240136972A/ko active Pending
- 2023-01-20 AU AU2023210279A patent/AU2023210279A1/en active Pending
- 2023-01-20 CN CN202380016422.5A patent/CN119053610A/zh active Pending
- 2023-01-20 MX MX2024008840A patent/MX2024008840A/es unknown
- 2023-01-20 JP JP2024540933A patent/JP7714811B2/ja active Active
- 2023-01-20 CA CA3242074A patent/CA3242074A1/en active Pending
- 2023-01-20 EP EP23707582.5A patent/EP4466273A1/en active Pending
- 2023-01-20 WO PCT/US2023/060944 patent/WO2023141536A1/en not_active Ceased
- 2023-01-20 AR ARP230100132A patent/AR128310A1/es unknown
-
2024
- 2024-03-05 US US18/595,898 patent/US20250066388A1/en not_active Abandoned
- 2024-07-15 CO CONC2024/0009334A patent/CO2024009334A2/es unknown
-
2025
- 2025-07-02 US US19/258,642 patent/US20260028356A1/en active Pending
- 2025-07-15 JP JP2025118767A patent/JP2025160251A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504382A5 (https=) | ||
| JP2012532874A5 (https=) | ||
| FI3672975T3 (fi) | Kondensoituja heterosyklisiä johdannaisia bcl-2-inhibiittoreina neoplastisten sairauksien hoitamiseksi | |
| JP2023027344A5 (https=) | ||
| US9056859B2 (en) | Inhibitors of the renal outer medullary potassium channel | |
| US9895349B2 (en) | N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| JP2018168191A5 (https=) | ||
| JP2015528821A5 (https=) | ||
| JP2009538861A5 (https=) | ||
| AR070236A1 (es) | Acido (-) 2-(1-(7-metil-2-(morfolin-4-il)-4-oxo-4h-pirido (1,2-a) pirimidin-9-il)etilamino) benzoico enantiomericamente puro su uso en terapia medica y una combinacion farmaceutica que comprende el compuesto | |
| CA2534024A1 (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
| WO2013066714A1 (en) | Inhibitors of the renal outer medullary potassium channel | |
| PE20160043A1 (es) | Forma de dosificacion farmaceutica para administracion oral de un inhibidor de la familia bcl-2 | |
| MX2010006260A (es) | Composiciones orales de abt-263 para tratar cancer. | |
| JP2009531376A5 (https=) | ||
| AR045499A1 (es) | Xantinas 8- heteroarilo sustituidas, composiciones farmaceuticas que las comprenden y su uso en la fabricacion de medicamentos antagonistas de los receptores a2b. | |
| TWI321084B (https=) | ||
| FI3894411T3 (fi) | 7-fenoksi-n-(3-atsabisyklo[3.2.1]oktan-8-yyli)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triatsoli-2-amiinijohdannaisia ja niihin liittyviä yhdisteitä gammasekretaasin modulaattoreina alzheimerin taudin hoitoon | |
| JP2009541443A5 (https=) | ||
| DOP2013000169A (es) | Compuesto para uso en el tratamiento de la artritis | |
| JP2006528617A5 (https=) | ||
| ECSP22098275A (es) | Formas de dosificación oral sólidas de combinación de antagonistas de la hormona liberadora de gonadotropina | |
| CY1110785T1 (el) | Ρυθμιστες δραστικοτητας υποδοχεων χημειοκινης, κρυσταλλικες μορφες και μεθοδος | |
| JP2023152927A5 (https=) | ||
| TW200732322A (en) | N-(heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |